2024-12-01 - Analysis Report
## Colgate-Palmolive Co (CL) Stock Report

**1. Performance Comparison & Overview:**

Colgate-Palmolive Co (CL) is a multinational consumer goods company specializing in oral hygiene, personal care, and household products.  The provided data shows that CL's cumulative return (50.34%) significantly underperformed the S&P 500 (VOO) cumulative return (130.06%) over the analyzed period.  The difference is -79.7%, placing it at the 7.3rd percentile of its historical relative performance compared to the S&P 500.  This indicates consistent underperformance relative to the broader market. The provided CAGR data shows fluctuating performance, sometimes outperforming, and sometimes underperforming the market. Beta consistently above 0 suggests sensitivity to market movements. Alpha consistently at 0 suggests it's mirroring market performance, aside from the cumulative return.

**2. Recent Price Movement:**

* **Closing Price:** $96.63
* **5-Day Moving Average:** $96.05
* **20-Day Moving Average:** $93.55
* **60-Day Moving Average:** $98.58

The price is slightly above the 5-day and 20-day moving averages, suggesting a recent upward trend, but below the 60-day moving average, indicating potential short-term momentum but a longer-term downward trend.  The closing price of 96.64 is not significantly different from the average price to suggest any drastic change.

**3. Technical Indicators & Expected Return:**

* **RSI:** 71.73 (Approaching overbought territory, suggesting potential near-term price correction)
* **PPO:** 0.80 (Positive value indicates upward momentum)
* **Delta_Previous_Relative_Divergence:** NaN (Insufficient data)
* **Expected Return:** 0.0% (This suggests the model predicts no significant outperformance relative to the S&P 500 over a long-term, 2+ year investment horizon.)


**4. Recent Earnings Analysis:**

The most recent earnings data shows relatively stable revenue around $5 billion, with a slight downward trend, yet remaining stable.  EPS shows a slight increase from Q1 2024 ($0.83) to Q3 2024 ($0.9).  There is no information provided on earnings expectations to determine if there were any beats or misses. The provided data does not show sufficient trends to determine any further conclusions, due to it only showing five quarters.


**5. Financial Information Analysis:**

* **Revenue & Profitability:** Revenue remained relatively stable over the past year, showing minor fluctuations. Profit margins have also been relatively stable, ranging from 58.54% to 61.08%.
* **Capital & Profitability:** Equity and ROE show significant volatility and unusual fluctuations (e.g., negative ROE in Q3 2023). This instability requires further investigation to understand the underlying causes.  ROE numbers seem to have some anomalies that require further investigation.

**6. News and Recent Issues:**

No recent news or market outlook information or analyst opinions were provided.  This is crucial information missing from the analysis.

**7. Overall Analysis:**

Colgate-Palmolive (CL) has shown consistent underperformance against the S&P 500 over the period analyzed. While recent price action shows some short-term upward momentum, technical indicators suggest caution.  The company's financial information exhibits volatility and requires additional examination to fully interpret the financial health.  The missing news and analyst information prevents a complete assessment of current market sentiment and future potential. The drastically unstable and fluctuating ROE requires further investigation to interpret any meaningful conclusions.  More information is needed, including the earnings expectations, in order to provide a thorough analysis.  Currently, the provided data lacks crucial details to provide a confident recommendation.


**8. Disclaimer:** This report is based solely on the limited data provided.  It is not financial advice and should not be used as the sole basis for investment decisions.  Conduct thorough independent research and consult with a financial advisor before making any investment choices.
